Atlas Trials

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Clinical trial NCT02008656 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02008656
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2013-11-01
Primary completion
2026-11-01
Enrollment
358

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.